Psychiatry and the pharmaceutical industry come under scrutiny in this examination of how mental illness diagnoses and drug treatments are marketed to the public. Interviews with doctors, former industry insiders, researchers, and critics lay out claims that conditions from ADHD to depression have been packaged and sold alongside the medications meant to treat them, with psychiatric manuals like the DSM presented as products of committee votes rather than hard science. The film traces the financial ties between pharmaceutical companies, medical associations, and regulators, and features testimony describing side effects and withdrawal problems tied to antidepressants and stimulants. Archival ads, congressional testimony clips, and case accounts from people prescribed psychiatric drugs as children are used to build the argument that diagnosis and treatment have become a commercial system as much as a medical one. It does not pretend to neutrality: this is an advocacy piece, built entirely around the case that psychiatric drugging has been oversold, but it makes that case through named sources and documented industry practices rather than assertion alone.